The Society for Healthcare Epidemiology of America (SHEA) says it is excited that the Senate has scheduled time to review the nomination of a new director of the Centers for Disease Control and Prevention (CDC). At a time when the nation continues to face evolving public health threats, strong, trusted, and qualified leadership at the CDC is essential to protecting the health and safety of all Americans, SHEA says

"The United States stands at a critical crossroads, where evidence-based public health leadership is needed to strengthen confidence in science, guide effective responses to emerging health challenges, and ensure the nation is prepared for future threats.," SHEA notes, adding, "The CDC plays a vital role in advancing infection prevention, antimicrobial stewardship, disease surveillance, outbreak response, and public health preparedness. Its ability to fulfill this mission depends on stable, credible leadership grounded in scientific integrity. While perspectives on public health policy may differ, the need for experienced leadership that prioritizes evidence-based decision-making and supports the CDC’s core mission remains paramount."

SHEA says it urges the Senate to give timely consideration to the nomination of Dr. Erica Schwartz to serve as director of the CDC. "Schwartz brings the experience, expertise, and leadership necessary to guide the agency at a time when trusted, science-driven public health leadership is essential. If confirmed, she should be empowered to lead the CDC with the authority and credibility needed to strengthen the nation’s public health infrastructure and restore confidence in this vital institution. SHEA looks forward to partnering with Dr. Schwartz and the CDC to advance infection prevention, combat antimicrobial resistance, strengthen antimicrobial stewardship, and improve the health and safety of patients and healthcare personnel across the country," SHEA says.

Source: Society for Healthcare Epidemiology of America